NCT04070300

Brief Summary

The purpose of the study is to determine the effect of aerobic interval training in patients with an implantable cardioverter defibrillator (ICD) on physical fitness, quality of life and the amount of serious ventricular arrhythmic events on short and long term.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

September 2, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2022

Completed
Last Updated

April 26, 2023

Status Verified

April 1, 2023

Enrollment Period

3 years

First QC Date

August 21, 2019

Last Update Submit

April 25, 2023

Conditions

Keywords

Exercise Training

Outcome Measures

Primary Outcomes (2)

  • Change in physical fitness/aerobic capacity

    Expressed in and measured with maximal oxygen uptake (VO2 peak)

    Change from baseline and after ended intervention period (12 weeks)

  • Change in assessment of quality of life

    Patient-reported survey of patient health SF-36

    Change from baseline and after intervention period (12 weeks)

Secondary Outcomes (20)

  • Change in burden of ventricular arrhythmias from baseline to week 9-12

    Baseline and the last 4 weeks of intervention period (week 9-12)

  • Change in burden of ventricular arrhythmias from baseline to week 13-16

    Baseline and the first 4 weeks after intervention period (week 13-16)

  • Change in burden of ventricular arrhythmias from baseline to week 9-16

    Baseline and the last 4 weeks of intervention period plus 4 first weeks after intervention period (week 9-16)

  • Change in burden of ventricular arrhythmias from baseline to week 9-12

    Baseline and the last 4 weeks of intervention period (week 9-12)

  • Change in burden of ventricular arrhythmias from baseline to week 13-16

    Baseline and the first 4 weeks after intervention period (week 13-16)

  • +15 more secondary outcomes

Study Arms (2)

Interval training group

EXPERIMENTAL

Aerobic interval training during 12 weeks 3 times a week.

Behavioral: Interval exercise

Control group

NO INTERVENTION

No lifestyle recommendations. Usual daily life.

Interventions

Aerobic interval training during 12 weeks 3 times a week: 4 x 4 minutes intervals at an intensity of 90-95% of VO2 peak and active breaks of 3 minutes between intervals.

Also known as: interval training, aerobic exercise training
Interval training group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ICD and dilated cardiomyopathy or coronary heart disease as cause for implantation
  • ICD implanted at St Olavs hospital, Trondheim

You may not qualify if:

  • inability to accomplish the exercise program due to serious comorbidity or to participate in regular training within the next 3 months due to other reasons
  • signs of severe cardiac ischemia or persistent ventricular tachycardia during individualized treadmill O2 peak test, which after individual assessment is to be found at risk
  • comorbidity where endurance training at more than moderate intensity is discouraged
  • severe cardiac valve disease
  • planned surgery within the next 3 months
  • inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Olavs Hospital

Trondheim, Norway

Location

MeSH Terms

Conditions

Tachycardia, Ventricular

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Rune Wiseth, MD, Prof

    St. Olavs Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2019

First Posted

August 28, 2019

Study Start

September 2, 2019

Primary Completion

September 2, 2022

Study Completion

September 2, 2022

Last Updated

April 26, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

Individual participant data for all primary and secondary outcome measures will be made available after deidentification and publication

Time Frame
After publication
Access Criteria
Not yet decided

Locations